Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincenza Conteduca

Showing results (51-60 of 157) with videos related to

Pageof 16
Sort By:
Molecular Cancer Therapeutics|March 9, 2026
Exploring DNA Damage Repair Therapeutics in Prostate Cancer beyond BRCAnessFabrizio Di Costanzo, Jack Williamson, Craig N Robson, et al.
Oncotarget|December 16, 2014
Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abirateroneUgo De Giorgi, Paola Caroli, Salvatore L Burgio, et al.
Current Cancer Drug Targets|November 28, 2017
AR Copy Number and AR Signaling-directed Therapies in Castrationresistant Prostate CancerSamanta Salvi, Vincenza Conteduca, Cristian Lolli, et al.
Clinical Genitourinary Cancer|July 8, 2014
PSA flare with abiraterone in patients with metastatic castration-resistant prostate cancerSalvatore L Burgio, Vincenza Conteduca, Britt Rudnas, et al.
The Oncologist|May 8, 2023
Pancreatic Enzyme Replacement and Nutritional Support With nab-Paclitaxel-based First-Line Chemotherapy Regimens in Metastatic Pancreatic CancerGuido Giordano, Raffaele Ivan Cincione, Francesca Losavio, et al.
Blood|March 24, 2010
Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term studyFranco Dammacco, Felicia Anna Tucci, Gianfranco Lauletta, et al.
Therapeutic Advances in Medical Oncology|March 12, 2021
Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imagingVincenza Conteduca, Giulia Poti, Paola Caroli, et al.
Clinical Genitourinary Cancer|December 4, 2014
Conditional survival of patients treated with first-line chemotherapy for metastatic urothelial cancerMatteo Santoni, Simon J Crabb, Alessandro Conti, et al.
Clinical Genitourinary Cancer|March 30, 2016
Correlation of Stomatitis and Cutaneous Toxicity With Clinical Outcome in Patients With Metastatic Renal-Cell Carcinoma Treated With EverolimusVincenza Conteduca, Matteo Santoni, Matelda Medri, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 8, 2017
Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamidePaola Caroli, Ugo De Giorgi, Emanuela Scarpi, et al.
Pageof 16

Showing results (51-60 of 157) with videos related to

Sort By:
Pageof 16
Molecular Cancer Therapeutics|March 9, 2026
Exploring DNA Damage Repair Therapeutics in Prostate Cancer beyond BRCAnessFabrizio Di Costanzo, Jack Williamson, Craig N Robson, et al.
Oncotarget|December 16, 2014
Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abirateroneUgo De Giorgi, Paola Caroli, Salvatore L Burgio, et al.
Current Cancer Drug Targets|November 28, 2017
AR Copy Number and AR Signaling-directed Therapies in Castrationresistant Prostate CancerSamanta Salvi, Vincenza Conteduca, Cristian Lolli, et al.
Clinical Genitourinary Cancer|July 8, 2014
PSA flare with abiraterone in patients with metastatic castration-resistant prostate cancerSalvatore L Burgio, Vincenza Conteduca, Britt Rudnas, et al.
The Oncologist|May 8, 2023
Pancreatic Enzyme Replacement and Nutritional Support With nab-Paclitaxel-based First-Line Chemotherapy Regimens in Metastatic Pancreatic CancerGuido Giordano, Raffaele Ivan Cincione, Francesca Losavio, et al.
Blood|March 24, 2010
Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term studyFranco Dammacco, Felicia Anna Tucci, Gianfranco Lauletta, et al.
Therapeutic Advances in Medical Oncology|March 12, 2021
Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imagingVincenza Conteduca, Giulia Poti, Paola Caroli, et al.
Clinical Genitourinary Cancer|December 4, 2014
Conditional survival of patients treated with first-line chemotherapy for metastatic urothelial cancerMatteo Santoni, Simon J Crabb, Alessandro Conti, et al.
Clinical Genitourinary Cancer|March 30, 2016
Correlation of Stomatitis and Cutaneous Toxicity With Clinical Outcome in Patients With Metastatic Renal-Cell Carcinoma Treated With EverolimusVincenza Conteduca, Matteo Santoni, Matelda Medri, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 8, 2017
Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamidePaola Caroli, Ugo De Giorgi, Emanuela Scarpi, et al.
Pageof 16